Annual EBITDA
-$15.33 M
-$2.75 M-21.83%
December 31, 2023
Summary
- As of February 8, 2025, KTTA annual EBITDA is -$15.33 million, with the most recent change of -$2.75 million (-21.83%) on December 31, 2023.
- KTTA annual EBITDA is now -605.97% below its all-time high of -$2.17 million, reached on December 31, 2021.
Performance
KTTA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.84 M
+$940.50 K+24.86%
September 30, 2024
Summary
- As of February 8, 2025, KTTA quarterly EBITDA is -$2.84 million, with the most recent change of +$940.50 thousand (+24.86%) on September 30, 2024.
- Over the past year, KTTA quarterly EBITDA has increased by +$940.50 thousand (+24.86%).
- KTTA quarterly EBITDA is now -848.96% below its all-time high of $379.50 thousand, reached on December 31, 2021.
Performance
KTTA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$15.49 M
+$784.80 K+4.82%
September 30, 2024
Summary
- As of February 8, 2025, KTTA TTM EBITDA is -$15.49 million, with the most recent change of +$784.80 thousand (+4.82%) on September 30, 2024.
- Over the past year, KTTA TTM EBITDA has increased by +$784.80 thousand (+4.82%).
- KTTA TTM EBITDA is now -110544.29% below its all-time high of -$14.00 thousand, reached on September 30, 2020.
Performance
KTTA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KTTA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.8% | +24.9% | +4.8% |
| 3 y3 years | - | +26.3% | -109.9% |
| 5 y5 years | - | +26.3% | -109.9% |
KTTA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -606.0% | at low | -849.0% | +43.0% | -613.3% | +4.8% |
| 5 y | 5-year | -606.0% | at low | -849.0% | +43.0% | <-9999.0% | +4.8% |
| alltime | all time | -606.0% | at low | -849.0% | +43.0% | <-9999.0% | +4.8% |
Pasithea Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.84 M(-24.9%) | -$15.49 M(-4.8%) |
| Jun 2024 | - | -$3.78 M(-2.5%) | -$16.27 M(+0.7%) |
| Mar 2024 | - | -$3.88 M(-22.2%) | -$16.16 M(+5.1%) |
| Dec 2023 | -$15.33 M(+21.8%) | -$4.99 M(+37.5%) | -$15.38 M(+6.6%) |
| Sep 2023 | - | -$3.63 M(-1.1%) | -$14.43 M(-1.6%) |
| Jun 2023 | - | -$3.67 M(+18.4%) | -$14.66 M(+7.8%) |
| Mar 2023 | - | -$3.10 M(-23.3%) | -$13.60 M(+15.3%) |
| Dec 2022 | -$12.58 M | -$4.04 M(+4.7%) | -$11.80 M(+59.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.86 M(+47.7%) | -$7.38 M(+53.8%) |
| Jun 2022 | - | -$2.61 M(+101.8%) | -$4.80 M(+64.6%) |
| Mar 2022 | - | -$1.29 M(-440.9%) | -$2.92 M(+34.3%) |
| Dec 2021 | -$2.17 M | $379.50 K(-129.8%) | -$2.17 M(-14.9%) |
| Sep 2021 | - | -$1.27 M(+75.0%) | -$2.55 M(+97.5%) |
| Jun 2021 | - | -$727.90 K(+32.4%) | -$1.29 M(+129.2%) |
| Mar 2021 | - | -$549.60 K(+3825.7%) | -$563.60 K(+3925.7%) |
| Sep 2020 | - | -$14.00 K | -$14.00 K |
FAQ
- What is Pasithea Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual EBITDA year-on-year change?
- What is Pasithea Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly EBITDA year-on-year change?
- What is Pasithea Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Pasithea Therapeutics?
- What is Pasithea Therapeutics TTM EBITDA year-on-year change?
What is Pasithea Therapeutics annual EBITDA?
The current annual EBITDA of KTTA is -$15.33 M
What is the all time high annual EBITDA for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual EBITDA is -$2.17 M
What is Pasithea Therapeutics annual EBITDA year-on-year change?
Over the past year, KTTA annual EBITDA has changed by -$2.75 M (-21.83%)
What is Pasithea Therapeutics quarterly EBITDA?
The current quarterly EBITDA of KTTA is -$2.84 M
What is the all time high quarterly EBITDA for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly EBITDA is $379.50 K
What is Pasithea Therapeutics quarterly EBITDA year-on-year change?
Over the past year, KTTA quarterly EBITDA has changed by +$940.50 K (+24.86%)
What is Pasithea Therapeutics TTM EBITDA?
The current TTM EBITDA of KTTA is -$15.49 M
What is the all time high TTM EBITDA for Pasithea Therapeutics?
Pasithea Therapeutics all-time high TTM EBITDA is -$14.00 K
What is Pasithea Therapeutics TTM EBITDA year-on-year change?
Over the past year, KTTA TTM EBITDA has changed by +$784.80 K (+4.82%)